Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of
the nation’s leading portfolio of handcrafted, natural ginger
beverages, is reporting financial results for the three months
ended March 31, 2024.
Q1 2024 Financial Highlights (vs. Q1 2023):
- Net sales were $9.6 million
compared to $11.2 million.
- Gross profit increased 26% to $3.4
million, with gross margin up 1,140 bps to 35.6%.
- Delivery and handling costs were
reduced by 29% to $3.01 per case.
- Selling, general and administrative
expenses were reduced by 19% to $2.6 million.
- Operating loss improved to $0.6
million compared to $2.6 million.
- Modified EBITDA loss improved to
$0.4 million compared to $2.3 million.
Management Commentary
“We continued to drive cost-cutting and
optimization initiatives in the first quarter, reflected by our
material improvements in gross margin, operating expenses and
modified EBITDA,” said Norman E. Snyder, Jr., CEO of Reed’s. “As
highlighted during our earnings call in March, Q1 sales were
impacted by short orders reducing shipments. However, we exited the
quarter with healthier inventory levels and have already seen a
reduction in the rate of short orders, which we expect to decline
further moving forward.
“Looking ahead, we are reiterating our 2024
financial outlook as we continue to expect net sales growth, gross
margin expansion, and modified EBITDA profitability while
generating positive cash flow from operations for the full year. We
have multiple initiatives to drive growth as we improve order
fulfillment rates, expand product authorizations, increase
promotional activity, and launch new innovative products later this
year. Between our improved inventory position, optimized cost
structure, and new product initiatives, we are poised for a strong
second quarter and year ahead.”
First Quarter 2024 Financial
Results
During the first quarter of 2024, net sales were
$9.6 million compared to $11.2 million in the year-ago period. The
decrease was primarily driven by tightened credit terms from select
suppliers that impacted the Company’s ability to purchase raw
materials, resulting in an inflated rate of short order
shipments.
Gross profit for the first quarter of 2024
increased 26% to $3.4 million compared to $2.7 million for the same
period in 2023. Gross margin increased 1,140 basis points to 35.6%
compared to 24.2% in the year-ago quarter. The increase was
primarily driven by lower supply chain and input costs.
Delivery and handling costs were reduced by 29%
to $1.5 million during the first quarter of 2024 compared to $2.1
million in the first quarter of 2023. The decrease was primarily
driven by renegotiated freight rates for heavily trafficked lanes,
improved throughput, as well as efficiencies generated from the
Company’s streamlined distribution model and new co-packing
partnership. Delivery and handling costs were reduced to 16% of net
sales or $3.01 per case, compared to 19% of net sales or $3.46 per
case during the same period last year.
Selling, general and administrative costs
declined by 19% to $2.6 million during the first quarter of 2024
compared to $3.2 million in the year-ago quarter. As a percentage
of net sales, selling, general and administrative costs were
reduced to 27% compared to 28%.
Operating loss during the first quarter of 2024
improved to $0.6 million or $(0.16) per share, compared to $2.6
million or $(1.01) per share in the first quarter of 2023.
Modified EBITDA loss improved to $0.4 million in
the first quarter of 2024 compared to $2.3 million in the first
quarter of 2023.
Liquidity and Cash Flow
For the first quarter of 2024, cash used in
operations was $2.4 million compared to cash flow from operations
of $1.1 million for the same period in 2023. The decrease in
operating cash flow was primarily driven by higher inventory
purchases compared to the year-ago period.
As of March 31, 2024, the Company had
approximately $0.3 million of cash and $26.0 million of total debt
net of capitalized financing fees. The debt includes $18.2 million
from a convertible note and $7.8 million from the Company’s
revolving line of credit, which has $5.0 million of additional
borrowing capacity.
FY 2024 Financial Outlook
The Company continues to project net sales
growth, gross margin expansion, and to achieve modified EBITDA
profitability for the full year 2024. Reed’s also expects to
generate positive cash flow from operations for the full year
2024.
Conference Call
The Company will conduct a conference call
today, May 14, 2024, at 5:00 p.m. Eastern time to discuss its
results for the three months ended March 31, 2024.
Reed’s management will host the conference call,
followed by a question-and-answer period.
Date: Tuesday, May 14, 2024Time: 5:00 p.m.
Eastern timeToll-free dial-in number: (888) 886-7786International
dial-in number: (416) 764-8658Conference ID: 71895807Webcast:
Reed’s Q1 2024 Conference Call
Please dial into the conference call 5-10
minutes prior to the start time. An operator will register your
name and organization. If you have any difficulty connecting with
the conference call, please contact the company’s investor
relations team at (720) 330-2829.
The conference call will also be broadcast live
and available for replay on the investor relations section of the
Company’s website at https://investor.reedsinc.com.
About Reed's, Inc.
Reed’s is an innovative company and category
leader that provides the world with high quality, premium and
naturally bold™ better-for-you beverages. Established in 1989,
Reed's is a leader in craft beverages under the Reed’s®, Virgil’s®
and Flying Cauldron® brand names. The Company’s beverages are now
sold in over 45,000 stores nationwide.
Reed’s is known as America's #1 name in natural,
ginger-based beverages. Crafted using real ginger and premium
ingredients, Reed’s portfolio includes ginger beers, ginger ales,
ready-to-drink ginger mules and hard ginger ales. The brand has
recently successfully expanded into the zero-sugar segment with its
proprietary, natural sweetener system.
Virgil's® is an award-winning line of craft
sodas, made with the finest natural ingredients and without GMOs or
artificial preservatives. The brand offers an array of great
tasting, bold flavored sodas including Root Beer, Vanilla Cream,
Black Cherry, Orange Cream, and more. These flavors are also
available in six zero sugar varieties which are naturally sweetened
and certified ketogenic.
Flying Cauldron® is a non-alcoholic butterscotch
beer prized for its creamy vanilla and butterscotch flavors. Sought
after by beverage aficionados, Flying Cauldron is made with natural
ingredients and no artificial flavors, sweeteners, preservatives,
gluten, caffeine, or GMOs.
For more information,
visit drinkreeds.com, virgils.com and flyingcauldron.com.
To receive exclusive perks for Reed’s investors, please visit the
Company’s page on the Stockperks app here.
Forward-Looking Statements
Statements in this release that are not
historical are forward-looking statements made pursuant to the safe
harbor provisions of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements are typically identified
by terms such as "estimate," "expect,” “intend,” "project," "will,"
“plan,” and similar expressions. These forward-looking statements
are based on current expectations and include our management’s
expectations and guidance for fiscal year 2024 under the heading
“FY 2024 Financial Outlook”. The achievement or success of the
matters covered by such forward-looking statements involves risks,
uncertainties, and assumptions, many of which involve factors or
circumstances that are beyond our control. Reed‘s 2024 guidance
reflects year-to-date and expected future business trends and
includes impacts of the inventory shortage as of the date hereof.
New supply chain challenges that may develop and further potential
inflation cannot be reasonably estimated and are not factored into
current fiscal 2024 guidance. These risks could materially impact
our ability to access raw materials, production, transportation
and/or other logistics needs.
Financial guidance should not be viewed as a
substitute for full financial statements prepared in accordance
with GAAP.
If any such risks or uncertainties materialize
or if any of the assumptions prove incorrect, Reed’s actual results
could differ materially from the results expressed or implied by
the forward-looking statements we make, including our ability to
achieve our targets for the fiscal year ending December 31, 2024.
The risks and uncertainties referred to above include, but are not
limited to: inventory shortages; risks associated with new product
releases; the impacts of further inflation; risks that customer
demand may fluctuate or decrease; risks that we are unable to
collect unbilled contractual commitments, particularly in the
current economic environment; our ability to compete successfully
and manage growth; our significant debt obligations; our ability to
develop and expand strategic and third party distribution channels;
our dependence on third party suppliers, brewers and distributors;
third party co-packers meeting contractual commitments; risks
related to our international operations; our ability to continue to
innovate; our strategy of making investments in sales to drive
growth; increasing costs of fuel and freight, protection of
intellectual property; competition; general political or
destabilizing events, including the wars in Ukraine and Israel,
conflict or acts of terrorism; financial markets, commodity and
currency impacts of the wars; the effect of evolving domestic and
foreign government regulations, including those addressing data
privacy and cross-border data transfers; and other risks detailed
from time to time in Reed’s public filings, including Reed’s annual
report on Form 10-K filed on April 1, 2024, which is available on
the Securities and Exchange Commission’s web site
at www.sec.gov. These forward-looking statements are based on
current expectations and speak only as of the date hereof. Reed’s
assumes no obligation and does not intend to update these
forward-looking statements, except as required by law.
Investor Relations Contact
Sean Mansouri, CFAElevate IRir@reedsinc.com (720) 330-2829
|
REED’S, INC. |
CONDENSED STATEMENTS OF OPERATIONS |
For the Three Months Ended March 31, 2024 and
2023 |
(Unaudited) |
(Amounts in thousands, except share and per share
amounts) |
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
March 31, |
|
2024 |
2023 |
Net Sales |
|
$ |
9,595 |
|
|
$ |
11,157 |
|
Cost of goods sold |
|
|
6,182 |
|
|
|
8,459 |
|
Gross profit |
|
|
3,413 |
|
|
|
2,698 |
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Delivery and handling expense |
|
|
1,502 |
|
|
|
2,120 |
|
Selling and marketing expense |
|
|
1,093 |
|
|
|
1,447 |
|
General and administrative expense |
|
|
1,468 |
|
|
|
1,709 |
|
Total operating expenses |
|
|
4,063 |
|
|
|
5,276 |
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
(650 |
) |
|
|
(2,578 |
) |
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(1,023 |
) |
|
|
(1,779 |
) |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,673 |
) |
|
$ |
(4,357 |
) |
|
|
|
|
|
|
|
|
|
Net loss per share – basic and diluted |
|
$ |
(0.40 |
) |
|
$ |
(1.70 |
) |
|
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding – basic and
diluted |
|
|
4,187,291 |
|
|
|
2,559,855 |
|
|
|
|
|
|
|
|
|
|
REED’S, INC, |
CONDENSED BALANCE SHEETS |
(Amounts in thousands, except share amounts) |
|
|
March 31, |
|
|
December 31, |
|
2024 |
2023 |
|
|
(Unaudited) |
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
314 |
|
|
$ |
603 |
|
Accounts receivable, net of allowance of $258 and $860,
respectively |
|
|
3,251 |
|
|
|
3,571 |
|
Inventory |
|
|
12,017 |
|
|
|
11,300 |
|
Receivable from former related party |
|
|
264 |
|
|
|
259 |
|
Prepaid expenses and other current assets |
|
|
2,332 |
|
|
|
2,028 |
|
Total current assets |
|
|
18,178 |
|
|
|
17,761 |
|
|
|
|
|
|
|
|
|
|
Property and equipment, net of accumulated depreciation of $1,136
and $1,068, respectively |
|
|
441 |
|
|
|
493 |
|
Intangible assets |
|
|
631 |
|
|
|
629 |
|
Total assets |
|
$ |
19,250 |
|
|
$ |
18,883 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
8,484 |
|
|
$ |
9,133 |
|
Accrued expenses |
|
|
872 |
|
|
|
1,096 |
|
Revolving line of credit, net of capitalized financing costs of
$161 and $201, respectively |
|
|
7,844 |
|
|
|
9,758 |
|
Payable to former related party |
|
|
331 |
|
|
|
259 |
|
Current portion of convertible notes payable, net of debt discount
of $509 and $424, respectively |
|
|
7,339 |
|
|
|
6,737 |
|
Current portion of lease liabilities |
|
|
155 |
|
|
|
207 |
|
Total current liabilities |
|
|
25,025 |
|
|
|
27,190 |
|
|
|
|
|
|
|
|
|
|
SAFE agreements |
|
|
4,097 |
|
|
|
- |
|
Convertible note payable, net of debt discount of $45 and $148,
respectively, less current portion |
|
|
10,853 |
|
|
|
10,874 |
|
Total liabilities |
|
|
39,975 |
|
|
|
38,064 |
|
|
|
|
|
|
|
|
|
|
Stockholders’ deficit: |
|
|
|
|
|
|
|
|
Series A Convertible Preferred stock, $10 par value, 500,000 shares
authorized, 9,411 shares issued and outstanding |
|
|
94 |
|
|
|
94 |
|
Common stock, $.0001 par value, 180,000,000 shares authorized;
4,187,291 and 4,187,291 shares issued and outstanding,
respectively |
|
|
- |
|
|
|
- |
|
Additional paid in capital |
|
|
119,581 |
|
|
|
119,452 |
|
Accumulated deficit |
|
|
(140,400 |
) |
|
|
(138,727 |
) |
Total stockholders’ deficit |
|
|
(20,725 |
) |
|
|
(19,181 |
) |
Total liabilities and stockholders’ deficit |
|
$ |
19,250 |
|
|
$ |
18,883 |
|
|
|
|
|
|
|
|
|
|
CONDENSED STATEMENTS OF CASH FLOWS |
For the Three Months Ended March 31, 2024 and
2023 |
(Unaudited) |
(Amounts in thousands) |
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
March 31, |
|
2024 |
2023 |
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(1,673 |
) |
|
$ |
(4,357 |
) |
Adjustments to reconcile net loss to net cash provided by (used in)
operating activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
29 |
|
|
|
47 |
|
Amortization of debt discount |
|
|
144 |
|
|
|
281 |
|
Fair value of vested options |
|
|
129 |
|
|
|
229 |
|
Fair value of vested restricted shares granted to officers |
|
|
- |
|
|
|
4 |
|
Change in allowance for doubtful accounts |
|
|
(601 |
) |
|
|
(39 |
) |
Inventory write-downs |
|
|
(783 |
) |
|
|
(228 |
) |
Accrued interest |
|
|
564 |
|
|
|
1,113 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
922 |
|
|
|
1,044 |
|
Inventory |
|
|
66 |
|
|
|
1,102 |
|
Prepaid expenses and other assets |
|
|
(1,305 |
) |
|
|
338 |
|
Decrease in right of use assets |
|
|
39 |
|
|
|
32 |
|
Accounts payable |
|
|
351 |
|
|
|
1,360 |
|
Accrued expenses |
|
|
(225 |
) |
|
|
235 |
|
Lease liabilities |
|
|
(52 |
) |
|
|
(44 |
) |
Net cash provided by (used in) operating
activities |
|
|
(2,395 |
) |
|
|
1,117 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Trademark costs |
|
|
(2 |
) |
|
|
- |
|
Purchase of property and equipment |
|
|
(16 |
) |
|
|
- |
|
Net cash used in investing activities |
|
|
(18 |
) |
|
|
- |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Proceeds from line of credit |
|
|
8,285 |
|
|
|
8,699 |
|
Payments on line of credit |
|
|
(10,239 |
) |
|
|
(12,120 |
) |
Proceeds from convertible note payable, net of expenses |
|
|
- |
|
|
|
2,405 |
|
Proceeds from SAFE agreement |
|
|
4,097 |
|
|
|
- |
|
Payment of cost recorded as debt discount |
|
|
(86 |
) |
|
|
|
|
Repurchase of common stock |
|
|
- |
|
|
|
(1 |
) |
Amounts from former related party, net |
|
|
67 |
|
|
|
(166 |
) |
Net cash provided by (used in) financing
activities |
|
|
2,124 |
|
|
|
(1,183 |
) |
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash |
|
|
(289 |
) |
|
|
(66 |
) |
Cash at beginning of period |
|
|
603 |
|
|
|
533 |
|
Cash at end of period |
|
$ |
314 |
|
|
$ |
467 |
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow
information: |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
318 |
|
|
$ |
390 |
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Reclass of prepaid expenses and accounts payable |
|
$ |
1,000 |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
Modified EBITDA
In addition to our GAAP results, we present Modified EBITDA as a
supplemental measure of our performance. However, Modified EBITDA
is not a recognized measurement under GAAP and should not be
considered as an alternative to net income, income from operations
or any other performance measure derived in accordance with GAAP,
or as an alternative to cash flow from operating activities as a
measure of liquidity. We define Modified EBITDA as net income
(loss), plus interest expense, tax expense, depreciation and
amortization, stock-based compensation, changes in fair value of
warrant expense, legal and insurance settlements, inventory
write-offs associated with exited categories and major packaging
and formula changes, one-time changes to policy for discounts,
impact of changes to accounting methodology and one-time
restructuring-related costs including employee severance and asset
impairment.
Management considers our core operating performance to be that
which our managers can affect in any particular period through
their management of the resources that affect our underlying
revenue and profit generating operations during that period.
Non-GAAP adjustments to our results prepared in accordance with
GAAP are itemized below. You are encouraged to evaluate these
adjustments and the reasons we consider them appropriate for
supplemental analysis. In evaluating Modified EBITDA, you should be
aware that in the future we may incur expenses that are the same as
or similar to some of the adjustments in this presentation. Our
presentation of Modified EBITDA should not be construed as an
inference that our future results will be unaffected by unusual or
non-recurring items.
Set forth below is a reconciliation of net loss to Modified
EBITDA for the three months ended March 31, 2024, and 2023
(unaudited; in thousands):
|
|
Three Months Ended |
|
March 31 |
|
|
2024 |
|
|
2023 |
|
Net loss |
|
$ |
(1,673 |
) |
|
$ |
(4,357 |
) |
|
|
|
|
|
|
|
|
|
Modified EBITDA adjustments: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
68 |
|
|
|
80 |
|
Tax expense |
|
|
54 |
|
|
|
|
|
Interest expense |
|
|
1,023 |
|
|
|
1,779 |
|
Product quality hold write-down |
|
|
29 |
|
|
|
|
|
Stock option and other noncash compensation |
|
|
129 |
|
|
|
233 |
|
Total EBITDA adjustments |
|
$ |
1,303 |
|
|
$ |
2,092 |
|
|
|
|
|
|
|
|
|
|
Modified EBITDA |
|
$ |
(370 |
) |
|
$ |
(2,265 |
) |
|
|
|
|
|
|
|
|
|
We present Modified EBITDA because we believe it assists
investors and analysts in comparing our performance across
reporting periods on a consistent basis by excluding items that we
do not believe are indicative of our core operating performance. In
addition, we use Modified EBITDA in developing our internal
budgets, forecasts, and strategic plan; in analyzing the
effectiveness of our business strategies in evaluating potential
acquisitions; making compensation decisions; and in communications
with our board of directors concerning our financial performance.
Modified EBITDA has limitations as an analytical tool, which
includes, among others, the following:
- Modified EBITDA does not reflect our
cash expenditures, or future requirements, for capital expenditures
or contractual commitments;
- Modified EBITDA does not reflect
changes in, or cash requirements for, our working capital
needs;
- Modified EBITDA does not reflect
future interest expense, or the cash requirements necessary to
service interest or principal payments, on our debts; and
- Although depreciation and
amortization are non-cash charges, the assets being depreciated and
amortized will often have to be replaced in the future, and
Modified EBITDA does not reflect any cash requirements for such
replacements.
Reeds (NASDAQ:REED)
Historical Stock Chart
From Oct 2024 to Nov 2024
Reeds (NASDAQ:REED)
Historical Stock Chart
From Nov 2023 to Nov 2024